Free Trial

Captrust Financial Advisors Has $3.09 Million Stake in Plexus Corp. (NASDAQ:PLXS)

Plexus logo with Computer and Technology background

Captrust Financial Advisors reduced its position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 14.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,761 shares of the technology company's stock after selling 3,325 shares during the period. Captrust Financial Advisors owned about 0.07% of Plexus worth $3,092,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of PLXS. Pacer Advisors Inc. bought a new position in shares of Plexus during the 4th quarter worth approximately $107,489,000. Barclays PLC grew its position in Plexus by 139.4% in the third quarter. Barclays PLC now owns 48,786 shares of the technology company's stock valued at $6,669,000 after purchasing an additional 28,406 shares in the last quarter. KBC Group NV increased its stake in Plexus by 59.9% in the 4th quarter. KBC Group NV now owns 1,180 shares of the technology company's stock valued at $185,000 after buying an additional 442 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new stake in Plexus during the 4th quarter worth about $783,000. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in shares of Plexus by 17.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 1,779 shares of the technology company's stock worth $278,000 after buying an additional 261 shares during the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.

Insiders Place Their Bets

In other news, insider Frank Zycinski sold 1,200 shares of Plexus stock in a transaction on Monday, February 10th. The stock was sold at an average price of $140.84, for a total transaction of $169,008.00. Following the completion of the sale, the insider now owns 723 shares of the company's stock, valued at approximately $101,827.32. This trade represents a 62.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Randy J. Martinez sold 887 shares of the company's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $140.52, for a total transaction of $124,641.24. Following the completion of the transaction, the director now owns 4,831 shares in the company, valued at $678,852.12. This trade represents a 15.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,337 shares of company stock worth $746,924 over the last three months. Insiders own 1.76% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Benchmark dropped their target price on Plexus from $170.00 to $160.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Needham & Company LLC reissued a "buy" rating and issued a $162.00 price objective (down previously from $172.00) on shares of Plexus in a report on Friday, April 25th. Finally, Stifel Nicolaus set a $145.00 target price on shares of Plexus in a research note on Thursday, April 24th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $155.67.

Read Our Latest Stock Analysis on PLXS

Plexus Stock Performance

PLXS opened at $126.14 on Friday. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of 29.27 and a beta of 0.80. Plexus Corp. has a 12-month low of $100.96 and a 12-month high of $172.89. The business has a 50 day moving average of $124.03 and a 200-day moving average of $143.42.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 EPS for the quarter, topping analysts' consensus estimates of $1.54 by $0.12. The firm had revenue of $980.17 million during the quarter, compared to analysts' expectations of $980.07 million. Plexus had a net margin of 3.03% and a return on equity of 10.36%. The company's revenue for the quarter was up 1.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.94 earnings per share. On average, equities research analysts expect that Plexus Corp. will post 5.9 earnings per share for the current year.

Plexus Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Recommended Stories

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS - Free Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines